These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 10566725)

  • 1. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS; Zlatanic J; Korelitz BI; Gleim GW
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ; Sandborn WJ; Tremaine WJ
    Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.
    Korelitz BI; Mirsky FJ; Fleisher MR; Warman JI; Wisch N; Gleim GW
    Am J Gastroenterol; 1999 Nov; 94(11):3248-53. PubMed ID: 10566724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Bouhnik Y; Lémann M; Mary JY; Scemama G; Taï R; Matuchansky C; Modigliani R; Rambaud JC
    Lancet; 1996 Jan; 347(8996):215-9. PubMed ID: 8551879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
    Mahdi G; Israel DM; Hassall E
    Am J Gastroenterol; 1996 Jul; 91(7):1355-9. PubMed ID: 8677994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse.
    Treton X; Bouhnik Y; Mary JY; Colombel JF; Duclos B; Soule JC; Lerebours E; Cosnes J; Lemann M;
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):80-5. PubMed ID: 18849016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
    Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
    Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A search for the optimal duration of treatment with 6-mercaptopurine for ulcerative colitis.
    Lobel EZ; Korelitz BI; Xuereb MA; Panagopoulos G
    Am J Gastroenterol; 2004 Mar; 99(3):462-5. PubMed ID: 15056086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate in Crohn's disease: long-term efficacy and toxicity.
    Lémann M; Zenjari T; Bouhnik Y; Cosnes J; Mesnard B; Rambaud JC; Modigliani R; Cortot A; Colombel JF
    Am J Gastroenterol; 2000 Jul; 95(7):1730-4. PubMed ID: 10925976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
    Zheng JJ; Chu XQ; Shi XH; Zhou CL; Seng BW
    J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
    Markowitz JF
    Rev Gastroenterol Disord; 2003; 3 Suppl 1():S23-9. PubMed ID: 12684586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease.
    Colonna T; Korelitz BI
    Am J Gastroenterol; 1994 Mar; 89(3):362-6. PubMed ID: 8122645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of medically induced remission of Crohn's disease.
    Gonvers JJ; Juillerat P; Mottet C; Pittet V; Felley C; Vader JP; Michetti P; Froehlich F
    Digestion; 2007; 76(2):116-29. PubMed ID: 18239403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Hibi T; Iwao Y; Yajima T; Inoue N; Ueno Y; Takaishi H; Watanabe M; Ishii H
    J Gastroenterol; 1995 Nov; 30 Suppl 8():121-3. PubMed ID: 8563872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment for prevention of relapse and recurrence in Crohn's disease.
    Prantera C; Scribano ML
    Ital J Gastroenterol Hepatol; 1999; 31(6):515-8. PubMed ID: 10575572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
    Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
    Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of Crohn's disease following corticosteroid-induced remission.
    Papi C; Festa V; Leandro G; Moretti A; Tanga M; Koch M; Capurso L
    Am J Gastroenterol; 2007 Apr; 102(4):814-9. PubMed ID: 17222316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease.
    Korelitz BI; Fuller SR; Warman JI; Goldberg MD
    Am J Gastroenterol; 1999 Feb; 94(2):424-6. PubMed ID: 10022640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.